Hearing loss in fibromyalgia? Somatic sensory and non-sensory symptoms in patients with fibromyalgia and other rheumatic disorders

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.74, 2012, Pages

  Wolfe, Frederick ^a   Rasker, Johannes J ^b   Hauser, Winfried ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Fibromyalgia; Polysymptomatic distress; Somatic symptoms

Indexed keywords

ADULT; ARTICLE; CENTRAL DYSREGULATION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM AUGMENTATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; HAIR LOSS; HEARING IMPAIRMENT; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RATING SCALE; RHEUMATOID ARTHRITIS; SELF REPORT; SKIN BRUISING; AGE; AGED; ALOPECIA; AUDITORY THRESHOLD; COMPARATIVE STUDY; CONTUSION; HEARING; MIDDLE AGED; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; STATISTICAL MODEL; VACCINATION;

INFLUENZA VACCINE;

AGE FACTORS; AGED; ALOPECIA; ARTHRITIS, RHEUMATOID; AUDITORY THRESHOLD; CONTUSIONS; FEMALE; FIBROMYALGIA; HEARING; HEARING LOSS; HUMANS; INFLUENZA VACCINES; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SENSORY THRESHOLDS; SEX FACTORS; VACCINATION;

EID: 84875001516     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. CLAUW DJ. Fibromyalgia. an overview. Am J Med 2009; 122 (12 Suppl.). S3-S13.
2. TRACEY I, BUSHNELL MC. How neuroimaging studies have challenged us to rethink. is chronic pain a disease J Pain 2009; 10. 1113-20.
3. WOOLF CJ. Central sensitization. implications for the diagnosis and treatment of pain. Pain 2011; 152 (3 Suppl.). S2-15.
4. DIATCHENKO L, NACKLEY AG, SLADE GD, FILLINGIM RB, MAIXNER W. Idiopathic pain disorders--pathways of vulnerability. Pain 2006; 123. 226-30.
5. AARON LA, BURKE MM, BUCHWALD D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Archives Int Med 2000; 160. 221-7.
6. WILLIAMS DA, CLAUW DJ. Understanding fibromyalgia. lessons from the broader pain research community. J Pain 2009; 10. 777-91.
7. WILLIAMS D, CLAUW D. Understanding fibromyalgia. Lessons from the broader pain research community. J Pain 2009; 10. 777-91.
8. MEASE PJ, CLAUW DJ, GENDREAU RM et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009; 36. 398-409.
9. BRADLEY LA. Pathophysiology of fibromyalgia. Am J Med 2009; 122. S22-S30.
10. BAZZICHI L, SERNISSI F, CONSENSI A, GIACOMELLI C, SARZI-PUTTINI P. Fibromyalgia. a critical digest of the recent literature. Clin Exp Rheumatol 2011; 29 (Suppl. 69). S1.
11. WOLFE F, HAWLEY DJ. Evidence of disordered symptom appraisal in fibromyalgia. increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol 1999; 17. 297-303.
12. WOLFE F, MICHAUD K, LI T, KATZ BS. Chronic conditions and health problems in rheumatic diseases. comparisons with ra, non-inflammatory rheumatic disorders, systemic lupus erythematosus and fibromyalgia. J Rheumatol 2010; 37. 305-15.
13. GEISSER ME, GLASS JM, RAJCEVSKA LD et al.. A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J Pain 2008; 9. 417-22.
14. HASHIMOTO H, NOMURA K, YANO E. Psychosomatic status affects the relationship between subjective hearing difficulties and the results of audiometry. J Clin Epidemiol 2004; 57. 381-5.
15. WOLFE F, MICHAUD K. Themed issues 2010. The National Data Bank for Rheumatic Diseases (NDB). a multi-registry rheumatic disease data bank. Rheumatology (Oxford) 2011; 50. 16-24.
16. WALITT B, FITZCHARLES MA, HASSETT AL, KATZ RS, HÄUSER W, WOLFE F. The Longitudinal Outcome of Fibromyalgia. A Study of 1555 Patients. J Rheum 2011; 38. 2238-47.
17. WOLFE F, CLAUW D, FITZCHARLES MA et al.. Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies. A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011; 38. 113-22.
18. WOLFE F, CLAUW D, FITZCHARLES MA et al.. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care Res 2010; 62. 600-10.
19. OTTENBERG AL, WU JT, POLAND GA, JACOBSON RM, KOENIG BA, TILBURT JC. Vaccinating health care workers against influenza. the ethical and legal rationale for a mandate. American Journal of Public Health 2011; 101. 212.
20. FIORE AE, UYEKI TM, BRODER K et al.. Prevention and control of influenza with vaccines. recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recommendations and reports. Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control. 2010; 59 (RR-8). 1.
21. WOLFE F. New Criteria for fibromyalgia. a twenty year journey. Arthritis Care Res 2010; 62. 583-4.
22. WOLFE F. Fibromyalgianess. Arthritis Rheum 2009; 61. 715-6.
23. Corporation S. Stata Statistical Software. Release 12.0. College Station, TX. Stata Corporation; 2011.
24. FINK P, SCHRODER A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 2010; 68. 415-26.
25. RIEF W, BARSKY AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005; 30. 996-1002.
26. BARSKY AJ, ETTNER SL, HORSKY J, BATES DW. Resource utilization of patients with hypochondriacal health anxiety and somatization. Medical Care 2001. 705-15.
27. RIEF W, HESSEL A, BRAEHLER E. Somatization symptoms and hypochondriacal features in the general population. Psychosom Med 2001; 63. 595-602.
28. KROENKE K, MANGELSDORF D. Common symptoms in ambulatory care. incidence, evaluation, therapy, outcome. Am J Med 1989; 86. 263-6.
29. KROENKE K, ARRINGTON ME, MANGELSDORF D. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990; 150. 1585-9.
30. AMERICAN PSYCHIATRIC A. Diagnostic and statistical manual of mental disorders (DSMIV). Washington. American Psychiatric Association; 1994.
31. WILHELMSEN I. Biological sensitisation and psychological amplification. gateways to subjective health complaints and somatoform disorders. Psychoneuroendocrinology 2005; 30. 990-5.
32. WESSELY S, HOTOPF M. Is fibromyalgia a distinct clinical entity Historical and epidemiological evidence. Baillieres Best Pract Res Clin Rheumatol 1999; 13. 427-36.
33. WHITEHEAD WE, PALSSON O, JONES KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders. What are the causes and implications Gastroenterology 2002; 122. 1140-56.
34. SALKOVSKIS PM, RIMES KA, WARWICK HM, CLARK DM. The Health Anxiety Inventory. development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002; 32. 843-53.
35. MCDERMID AJ, ROLLMAN GB, MCCAIN GA. Generalized hypervigilance in fibromyalgia. Evidence of perceptual amplification. Pain 1996; 66. 133-44.
36. ARNOLD LM, HUDSON JI, HESS EV et al.. Family study of fibromyalgia. Arthritis Rheum 2004; 50. 944-52.
37. RAPHAEL KG, JANAL MN, NAYAK S, SCHWARTZ JE, GALLAGHER RM. Familial aggregation of depression in fibromyalgia. a community-based test of alternate hypotheses. Pain 2004; 110. 449-60.
38. THIEME K, TURK DC, FLOR H. Comorbid depression and anxiety in fibromyalgia syndrome. relationship to somatic and psychosocial variables. Psychosom Med 2004; 66. 837-44.
39. ISIK A, KOCA SS, OZTURK A, MERMI O. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 2007; 26. 872-8.
40. NYKLICEK I, VINGERHOETS AJJM. Alexithymia is associated with low tolerance to experimental painful stimulation. Pain 2000; 85. 471-5.
41. SAYAR K, GULEC H, TOPBAS M. Alexithymia and anger in patients with fibromyalgia. Clin Rheumatol 2004; 23. 441-8.
42. ROBBINS JM, KIRMAYER LJ, KAPUSTA MA. Illness worry and disability in fibromyalgia syndrome. Int J Psychiatry Med 1990; 20. 49-63.
43. LAUTENBACHER S, ROLLMAN GB, BLOCK AR, KREMER EF, FERNANDEZ E. Somatization, hypochondriasis, and related conditions. Handbook of pain syndromes. biopsychosocial perspectives. Mahwah. Lawrence Erlbaum Associates; 1999; 613-32.
44. KIRMAYER LJ, ROBBINS JM, KAPUSTA MA. Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 1988; 145. 950-4.
45. FINK P. Somatization Beyond symptom count. J Psychosom Res. 1996; 40. 7-10.
46. WILHELMSEN I. Somatization, sensitization, and functional dyspepsia. Scand J Psychol 2002; 43. 177-80.
47. STAUD R, SPAETH M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr 2008; 13 (Suppl. 5). 12-7.
48. ARNOLD LM. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther 2006; 8. 212.
49. SCHMIDT-WILCKE T, CLAUW DJ. Fibromyalgia. from pathophysiology to therapy. Nat Rev Rheumatol 2011; 19. 518-27.